Monocyte infiltration and c-fms expression in hearts of spontaneously hypertensive rats

Hypertension

Volumn 25, Issue 1, 1995, Pages 132-138

  Haller, Hermann ^a   Behrend, Martin ^b   Park, Joon Keun ^b   Schaberg, Tom ^b   Luft, Friedrich C ^b   Distler, Armin ^b  

^a FRANZ VOLHARD CLINIC   (Germany)

^b NONE

Author keywords

fibrosis; heart hypertrophy; macrophages; monocytes; oncogenes

Indexed keywords

MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; GENE EXPRESSION; HEART; HEART VENTRICLE HYPERTROPHY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MONOCYTE; NONHUMAN; NORTHERN BLOTTING; ONCOGENE C FOS; ONCOGENE C MYC; PRIORITY JOURNAL; PROTO ONCOGENE; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0028906601     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.25.1.132     Document Type: Article

References (26)

1. Kannel WB, Levy D, Cupples LA. Left ventricular hypertrophy and risk of cardiac failure: insights from the Framingham study. J Cardiovasc Pharmacol. 1987;10:S135-S140.
2. Brilla CG, Maisch B, Weber KT. Renin-angiotensin system and myocardial collagen matrix remodeling in hypertensive heart disease: in vivo and in vitro studies on collagen matrix regulation. J Clin Invest. 1993;71:S35-S41.
3. Simpson PC. Proto-oncogenes and cardiac hypertrophy. Annu Rev Physiol. 1988;51:189-202.
4. Komuro I, Krabayashi M, Takaku F, Yazaki Y. Expression of cellular oncogenes in the myocardium during the developmental stage and pressure-overloaded hypertrophy of the rat heart. Circ Res. 1988;62:1075-1079.
5. Mai M, Geiger H, Hilgers KF, Veelken R, Mann JFE, Luft FC. Early interstitial changes in hypertension-induced renal injury. Hypertension. 1993;22:754-765.
6. Chirgwin J, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979;18:5294-5299.
7. Curran T, Teich NM. Candidate product of the FBJ murine osteosarcoma virus oncogene: characterization of a 55,000 dalton phosphoprotein. J Virol. 1982;42:114-122.
8. Muller R, Muller D, Guilbert L. Differential expression of c-fos in hematopoietic cells: correlation with differentiation of monomyelocytic cells in vitro. EMBO J. 1984;3:1887-1890.
9. Campici J, Gray HE, Pardee AB, Dean M, Sonenshein GE. Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation. Cell. 1984;36:241-247.
10. Makino R, Hayashi K, Sugimura T. c-myc transcript is induced in rat liver at a very early stage of regeneration or by cycloheximide treatment. Nature. 1984;310:697-698.
11. Starksen NF, Simpson PC, Bishopric N, Coughlin SR, Lee WMF, Escobedo JA, Williams LT. Cardiac myocyte hypertrophy is associated with c-myc proto-oncogene expression. Proc Natl Acad Sci U S A. 1986;83:8348-8350.
12. Iwaki K, Sukhatme VP, Shubeita HE, Chien KR. α- and β-adrenergic stimulation induces distinct patterns of immediate early gene expression in neonatal rat myocardial cells. J Biol Chem. 1990;265:13809-13817.
13. Long CS, Kariy K, Karns L, Simpson PC. Trophic factors for cardiac myocytes. J Hypertens. 1990;8(suppl 7):S219-S224.
14. Green NK, Gammage MD, Franklyn JA, Heagerty AM, Sheppard MC. Regulation of beta myosin heavy chain, c-myc and c-fos protooncogenes in thyroid hormone-induced hypertrophy of the rat myocardium. Clin Sci. 1993;84:61-67.
15. Dolittle RF, Hunkapiller MW, Hood LE. Simian sarcoma virus oncogene, v-sis, is derived from the gene (orgenes) encoding a platelet-derived factor. Science. 1983;221:275-277.
16. Claycomb WC, Lanson NA. Proto-oncogene expression in proliferating and differentiating cardiac and skeletal muscle. Biochem J. 1987;247:701-706.
17. Weber KT, Janicki JS, Shroff SG, Pick R, Chen RM, Bashey RI. Collagen remodeling of the pressure-overloaded hypertrophied nonhuman primate myocardium. Circ Res. 1988;62:757-765.
18. Jalil JE, Janicki JS, Pick R, Abrahams C, Weber KT. Fibrosis-induced reduction of endomyocardium in the rat after isoproterenol treatment. Circ Res. 1989;65:258-264.
19. Dzau VJ. Significance of the vascular renin-angiotensin pathway. Hypertension. 1986;8:553-559.
20. Brilla CG, Janicki JS, Weber KT. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation. 1991;83:1771-1779.
21. Nathan CF. Secretory products of macrophages. J Clin Invest. 1987;79:319-326.
22. Lindpaintner K, Ganten D. The cardiac renin-angiotensin system: an appraisal of present and experimental evidence. Circ Res. 1991;68:905-921.
23. Campbell DJ. Circulating and tissue angiotensin systems. J Clin Invest. 1987;79:1-6.
24. Sun Y, Ratajska A, Zhou G, Weber KT. Angiotensin converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone. J Lab Clin Med. 1993;122:395-403.
25. Rohrbach MS, DeRemmee RA. Pulmonary sarcoidosis and serum angiotensin-converting enzyme. Mayo Clin Proc. 1982;57:64-71.
26. Chambers SK, Gilmore-Hebert M, Wang Y, Rodov S, Benz E Jr, Kacinski BM. Posttranscriptional regulation of colony-stimulating factor-1 (CSF-1) and CSF-1 receptor gene expression during inhibition of phorbol-ester-induced monocytic differentiation by dexamethasone and cyclosporin A: potential involvement of a destabilizing protein. Exp Hematol. 1993;21:1328-1334.